Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-04-30 Quart Barry D Chief Executive Officer Other acquisition +806 $18.43 $15K 90,081
2019-04-30 MANHARD KIMBERLY Executive VP, Drug Development Other acquisition +1,109 $18.43 $20K 1,109
2018-12-15 Rosen Robert President Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2018-12-15 Quart Barry D Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +300,000 300,000
2018-12-15 MANHARD KIMBERLY Executive VP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +100,000 100,000
2018-12-15 HOFFMAN ROBERT CFO & SVP, Finance Grant or award · Employee Stock Option (Right to Buy) +71,000 71,000
2018-12-15 Christian Waage Director Grant or award · Stock Option (Right to Buy) +17,000 17,000
2018-12-15 POYHONEN JOHN Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2018-12-15 POYHONEN JOHN Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2018-12-15 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +21,000 21,000
2018-12-15 TANG KEVIN C Director Grant or award · Stock Option (right to buy) +17,000 17,000
2018-11-02 MANHARD KIMBERLY Executive VP, Drug Development Sale −494 $30.62 $15K 0
2018-10-31 MANHARD KIMBERLY Executive VP, Drug Development Other acquisition +494 $23.60 $12K 494
2018-10-01 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion +6,000 $13.00 $78K 6,000
2018-10-01 MANHARD KIMBERLY Executive VP, Drug Development Sale −6,000 $32.07 $192K 0
2018-10-01 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion · Employee Stock Option (Right to Buy) −6,000 82,416
2018-09-14 Quart Barry D Chief Executive Officer Exercise or conversion +19,675 $7.20 $142K 89,275
2018-09-14 Quart Barry D Chief Executive Officer Exercise or conversion · Employee Stock Option (Right to Buy) −19,675 710,601
2018-09-12 TANG KEVIN C Director Sale −2,695,000 $35.75 $96.3M 5,830,215
2018-07-02 MANHARD KIMBERLY Executive VP, Drug Development Exercise or conversion +6,000 $13.00 $78K 6,000

Page 31 of 38 · 746 trades